SCHEMBL16333323

SCHEMBL16333323

CN(CCc1ccccc1N1CC[C@H](O)C1)C(=O)Cc1ccccc1N

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 2/20 0.40
SIGMAR1 Q99720 4/20 0.38
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
GAA P10253 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
NAPEPLD Q6IQ20 3/20 0.34
SLC16A3 O15427 2/20 0.33
SLC16A1 P53985 2/20 0.33
AOC3 Q16853 1/20 0.32
CYP2D6 P10635 1/20 0.32
SMARCA2 P51531 1/20 0.32
SMARCA4 P51532 1/20 0.32
PBRM1 Q86U86 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8701795 0.87 LTB4R (0.43) OPRK1SIGMAR1NAPEPLDCYP2D6
SCHEMBL16333376 0.84 SIGMAR1 (0.57) OPRK1SIGMAR1KMT2AMEN1SIRT2
SCHEMBL8704031 0.82 MAPT (0.38) OPRK1SIGMAR1KMT2AMEN1
SCHEMBL8702756 0.82 OPRM1 (0.46) OPRK1SIGMAR1
SCHEMBL16333452 0.81 KCNH2 (0.47) OPRK1SIGMAR1CYP2D6
SCHEMBL6249500 0.81 OPRK1 (0.49) OPRK1KMT2AMEN1NAPEPLDSLC16A3
SCHEMBL6250215 0.80 OPRK1 (0.50) OPRK1NAPEPLDCYP2D6
SCHEMBL6472157 0.79 OPRK1 (0.54) OPRK1CYP2D6
Hydrochloric Acid SCHEMBL6477279 0.79 OPRM1 (0.40) OPRK1CYP2D6
SCHEMBL6251298 0.79 CYP2D6 (0.52) OPRK1SIGMAR1NAPEPLDSLC16A3SLC16A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013812-A2 KAPPA OPIOID AGONISTS AND USES THEREOF Nektar Therapeutics (US) 2016-05-04 EP disclosed
WO-2014210436-A2 KAPPA OPIOID AGONISTS AND USES THEREOF NEKTAR THERAPEUTICS (US) 2014-12-31 WO disclosed